SPOTLIGHT: Lilly to pay $500M to settle Zyprexa claims

Eli Lilly has agreed to pay as much as $500 million to settle 18,000 claims that people who took the drug developed diabetes. Previous data indicated that patients on Zyprexa were 3.5 times more likely to experience elevated blood sugar levels than volunteers taking a placebo, and the disease is heavily influenced by weight gain and blood sugar levels. Report

Post a comment